Pure Global
NCT06239025

Efficacy of Transversus Thoracis Muscle Plane Block in Patients Undergoing Cardiac Surgery

Efficacy of Transversus Thoracis Muscle Plane Block in Patients Undergoing Cardiac Surgery. A Randomized Controlled, Double Blind Trial
Hôpital du Valais·Phase 4·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Postoperative Pain
Drug/Device/Intervention
ultrasound-guided Transversus Thoracis Muscle Plane Block
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Hôpital du Valais
Location
Sion, Switzerland
Timeline & enrollment
Phase
Phase 4
Start date
Apr 01, 2024
End date
Apr 30, 2026
Enrollment
100 participants
Primary outcome

opioid consumption

Summary

The goal of this randomized double blind study is to evaluate the analgesic efficacy of
 Transversus Thoracis Muscle Plane Block in patients undergoing cardiac surgery with median
 sternotomy.
 
 one group of participants will receive multimodal analgesia plus ultrasound-guided
 Transversus Thoracis Muscle Plane Block with ropivacaine 0.5 % after induction of general
 anesthesia, the other group will receive multimodal analgesia without a bloc.
 
 The investigators want to know if participants who receive the Transversus Thoracis Muscle
 Plane Block with ropivacaine have less pain than participants who do not receive a block.

ICD-10 classifications
Acute painPostoperative intestinal obstructionPain, unspecifiedDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06239025
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06239025 through Pure Global AI's free database. This Phase 4 trial is sponsored by Hôpital du Valais and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.